Catalyst Wire Dossier Catalyst Wire Dossier

APSTZD

· Apsen Farmaceutica S.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for APSTZD, covering 2026-02-19 to 2026-02-19. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of APSTZD in the Treatment of Insomnia Disorder [Phase 2]

See pricing